Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. Leucovorin
may increase the effectiveness of fluorouracil by making tumor cells more sensitive to the
drug.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of
oxaliplatin, fluorouracil, and leucovorin in treating patients who have colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health